For research use only
| Cat No. | ABC-TC3163 |
| Product Type | Mouse Primary Cells |
| Cell Type | Fibroblast |
| Species | C57BL/6 Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Aortic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
C57BL/6 Mouse Primary Aortic Fibroblasts from AcceGen are isolated from tissue of pathogen-free laboratory mice.
C57BL/6 Mouse Aortic Fibroblasts are isolated from the aortic tissue of C57BL/6 mice and represent a specialized population of mouse fibroblasts within the vascular wall. Morphologically, these cells display a spindle-shaped to polygonal form and grow adherently, forming monolayers in culture. As vascular-derived fibroblasts, they express the marker vimentin. These fibroblasts regulate the mechanical tension, inflammatory responses, and tissue repair of the vascular wall by secreting ECM components and cytokines (e.g., TGF-β, IL-6). They play a pivotal role in the pathogenesis of diseases such as atherosclerosis, hypertension, and vascular fibrosis. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | C57BL/6 Mouse Aortic Fibroblasts,Mouse Aortic Fibroblasts,Vascular Fibroblasts,Fibroblasts,FBs,C57BL/6 MAFs |
| Species | C57BL/6 Mouse |
| Cat.No | ABC-TC3163 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Aortic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
C57BL/6 Mouse Aortic Fibroblasts can be used to explore the mechanism of action of fibroblasts in vascular construction, homeostasis maintenance, and injury repair. These cells can also be applied to evaluate the effects of drugs on the proliferation, migration, and extracellular matrix synthesis of vascular fibroblasts, and to screen for drug candidates with anti-fibrosis or vascular protective effects.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).